Lin Xu
- Molecular Biology top 5%
- Immunology top 2%
- Cancer Research top 1%
- Oncology top 5%
- Surgery top 10%
- Co-authors
- Ya ZhouZhenke WenJuanjuan ZhaoMengmeng GuoCesar V. BorlonganGiora FeuersteinSidong XiongChao Chen
- Topics
- MicroRNA in disease regulation (41 papers)Cancer-related molecular mechanisms research (28 papers)Circular RNAs in diseases (25 papers)
- Journals
- Journal of Biological ChemistryJournal of NeuroscienceSHILAP Revista de lepidopterología
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lin Xu
196 papers receiving 4.6k citations
Peers
Comparison fields: 5 of 141
- Molecular Biology 2.2k
- Immunology 1.1k
- Cancer Research 1.1k
- Oncology 696
- Surgery 522
Countries citing papers authored by Lin Xu
This map shows the geographic impact of Lin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Xu more than expected).
Fields of papers citing papers by Lin Xu
This network shows the impact of papers produced by Lin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Xu. The network helps show where Lin Xu may publish in the future.
Co-authorship network of co-authors of Lin Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Lin Xu. A scholar is included among the top collaborators of Lin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lin Xu. Lin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 19 | |
| 6 | 7 | |
| 7 | 3 | |
| 8 | Delicaflavone Reverses Cisplatin Resistance via Endoplasmic Reticulum Stress Signaling Pathway in Non-Small Cell Lung Cancer Cells | 1 |
| 9 | 3 | |
| 10 | 7 | |
| 11 | 8 | |
| 12 | 48 | |
| 13 | [miR-126 knockdown enhances the activity of murine CD4+ T cells in vivo and promotes their differentiation into Th1 cells]. | 4 |
| 14 | 21 | |
| 15 | Study of the effect of bone marrow cells from different grade of mice on the preparation of predominant DC2. | 0 |
| 16 | 9 | |
| 17 | 228 | |
| 18 | Clinical Pharmacokinetics of Ranibizumab (LucentisTM) in Subjects With AMD | 7 |
| 19 | Cellular vacuolization induced by truncated large surface antigen of hepatitis B virus due to pregenomic RNA splicing | 1 |
| 20 | 16 |
About Lin Xu
Lin Xu is a scholar working on Cancer Research, Immunology and Developmental Neuroscience, having authored 202 papers that have together received 4.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (41 papers), Cancer-related molecular mechanisms research (28 papers) and Circular RNAs in diseases (25 papers). The work is most often cited by research in Cancer Research (1.1k citations), Developmental Neuroscience (252 citations) and Immunology (1.1k citations). Lin Xu has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Ya Zhou, Zhenke Wen, Juanjuan Zhao, Mengmeng Guo, Cesar V. Borlongan, Giora Feuerstein, Sidong Xiong, Chao Chen, Wei Xu and Takao Yasuhara. Their work appears in journals such as Journal of Biological Chemistry, Journal of Neuroscience and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.